LFCR Q1 2022 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$42M-69.3% YoY

Gross Profit

$10M25.1% margin

Operating Income

-$3M-6.6% margin

Net Income

-$9M-22.8% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-70.2%

Cash Flow

Operating Cash Flow

$831,000

Free Cash Flow

-$7M

Stock-Based Comp.

$620,000

Balance Sheet

Total Assets

$446M

Total Liabilities

$252M

Stockholders' Equity

$194M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$136M	-69.3%
Gross Profit	$10M	$16M	-36.2%
Operating Income	-$3M	-$12M	+78.0%
Net Income	-$9M	-$11M	+13.8%